naltrexone has been researched along with Convulsions, Grand Mal in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bahremand, A; Dehpour, AR; Ghasemi, M; Gholizadeh, S; Nasrabady, SE; Shafaroodi, H | 1 |
Misawa, M; Mizoguchi, H; Nagase, H; Narita, M; Suzuki, T; Takahashi-Nakano, Y; Tseng, LF; Yajima, Y | 1 |
Castro-Souza, C; Coimbra, NC; Freitas, RL; Kishi, R; Resende, GC; Savoldi, M; Segato, EN; Weltson, A | 1 |
Hamilton, RJ; Hoffman, RS; Howland, MA; Hung, OL; Lewin, NL; Nelson, LS; Olmedo, RE; Perrone, J; Shah, S | 1 |
4 other study(ies) available for naltrexone and Convulsions, Grand Mal
Article | Year |
---|---|
The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice.
Topics: Animals; Anticonvulsants; Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoids; Convulsants; Dose-Response Relationship, Drug; Drug Synergism; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Injections, Intraperitoneal; Male; Mice; Naltrexone; Narcotic Antagonists; Pentylenetetrazole; Piperidines; Pyrazoles; Seizures | 2008 |
Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Bicuculline; Brain Chemistry; Convulsants; Enkephalin, D-Penicillamine (2,5)-; Epilepsy, Tonic-Clonic; Injections, Intraventricular; Injections, Subcutaneous; Male; Mice; Morphine; Naltrexone; Narcotic Antagonists; Quinolines; Receptors, GABA-A; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Seizures; Synaptic Transmission | 2000 |
Opioid neurotransmission in the post-ictal analgesia: involvement of mu(1)-opioid receptor.
Topics: Analgesia; Animals; Convulsants; Epilepsy, Temporal Lobe; Epilepsy, Tonic-Clonic; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pain Threshold; Pentylenetetrazole; Rats; Rats, Wistar; Receptors, Opioid, mu; Synaptic Transmission | 2001 |
Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets.
Topics: Administration, Cutaneous; Adult; Delayed-Action Preparations; Drug Implants; Emergency Treatment; Epilepsy, Tonic-Clonic; Fatal Outcome; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pulmonary Edema; Risk Assessment; Substance Withdrawal Syndrome; Time Factors; Unconsciousness; Vomiting | 2002 |